A clinical strategy where therapeutic adjustments are directly dictated by objective, quantifiable data derived from specific physiological markers, often including hormone levels or metabolic intermediates. This approach moves away from generalized protocols toward individualized treatment plans based on measurable deviations from optimal ranges. It mandates continuous feedback for refinement.
Origin
This term originates from the evolution of personalized medicine, emphasizing data-informed decision-making over empirical trial-and-error. In endocrinology, it signifies the reliance on detailed lab work—the biomarkers—to steer the intervention. The “driven” aspect highlights the biomarker’s authoritative role in protocol design.
Mechanism
The process initiates with baseline biomarker assessment, followed by targeted intervention designed to shift a specific value toward a desired physiological target. Subsequent testing confirms the intervention’s effect on that marker, allowing for titration or modification of the strategy. This iterative loop ensures that care remains precisely aligned with the patient’s evolving internal physiological state.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.